Melanotan 1

INVESTIGATIONAL

α-MSH analog | Tanning and photoprotection

By the INFOPEPTIDOS editorial team · content based on scientific literature.

Updated: August 2026.

Melanotan 1 — Analog of the α-MSH hormone (afamelanotide). It is mainly researched for tanning and skin photoprotection. Typical dose: 0.5–1 mg subcutaneous, loading then maintenance. Afamelanotide approved for a rare disease; not FDA-approved for cosmetic tanning.
Typical dose
0.5-1 mg
Per pigmentation
Route
Injectable
Subcutaneous
Cycle
Loading and maintenance
Typical duration
Storage
2-8 °C
Refrigerated

Key points

Technical data: Molecular formula C78H111N21O19 · Molecular weight 1646.8 g/mol. Source: PubChem.

Overview

What is Melanotan 1?

Melanotan 1 (afamelanotide) is an analog of melanocyte-stimulating hormone (α-MSH). It stimulates melanin production to tan the skin and protect it from ultraviolet radiation. Unlike Melanotan 2, it is more selective and does not produce the effect on sexual function.

Key benefits

More even tanning and photoprotection, with less nausea and without the erection/libido effect of Melanotan 2. Its pharmaceutical form (afamelanotide, Scenesse) is approved to protect the skin in a rare photosensitivity disease.

Mechanism of action

It acts as a melanocortin-1 receptor (MC1R) agonist on melanocytes, stimulating melanin synthesis. Its greater selectivity for MC1R explains why it tans with hardly any effect on the sexual-function pathways (MC4R).

Quick start guide

Typical dose
0.5-1 mg
Frequency
Daily loading; then maintenance
Where to inject
Subcutaneous (abdomen)
Timing
With moderate sun exposure to activate
Effects timeline
Pigmentation in 1-2 weeks
Storage
Refrigerate at 2-8 °C
Cycle length
Loading and maintenance
Monitor
Moles and freckles

Dosing protocol

PhaseDoseFrequencyGoal
Loading0.5 mgDailyReach pigmentation
Maintenance0.5–1 mg1–2 times/weekMaintain the tan

Subcutaneous route. Monitor moles and avoid excessive sun exposure. The specific dose must be assessed by a healthcare professional.

Reconstitution: units in the syringe

Example with a 10 mg vial + 2 ml of bacteriostatic water → a 5 mg/ml solution. On a U-100 insulin syringe (100 units = 1 ml):

DoseVolumeUnits (U-100)
0.5 mg0.10 ml10 U
1 mg0.20 ml20 U

Is your vial or water different? Calculate the exact units below.

🧮 Calculate your exact syringe dose →

Melanotan 1 vs Melanotan 2

 Melanotan 1Melanotan 2
TanningYesYes
Sexual effectNoYes
NauseaLessMore
SelectivityHigher (MC1R)Lower

⚠️ Who should NOT use it

What to expect

Side effects & safety

Frequently asked questions

What is Melanotan 1?

It is an α-MSH analog (afamelanotide) that stimulates melanin to tan and protect the skin.

How does it differ from Melanotan 2?

Melanotan 1 tans without the sexual effect and with less nausea; Melanotan 2 adds a libido effect.

What is the Melanotan 1 dose?

A loading of 0.5 mg daily until pigmented, then maintenance. The regimen is set by a professional.

Does Melanotan 1 protect from the sun?

It stimulates melanin, which provides some photoprotection; its approved form is used in a photosensitivity disease.

What are the side effects?

Mild nausea and darkening of moles and freckles; moles should be monitored.

Is Melanotan 1 approved?

Afamelanotide is approved for a rare disease, but not for cosmetic tanning.

Research areas

Related peptides

Related articles

Related topics

Summary

What it is: α-MSH analog (afamelanotide).

How it is researched: Subcutaneous, 0.5-1 mg, loading and maintenance.

Key features: Tans without a sexual effect, with less nausea. Not approved for aesthetics.

Related peptides: Melanotan 2, PT-141 and GHK-Cu.

References

  1. Habbema L et al. (2017). Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. Int J Dermatol. PubMed · DOI
  2. Chawathe A et al. (2026). Investigation of the stability profile of therapeutic α-MSH analogue: Insights from liquid chromatography-high resolution mass spectrometry analysis of afamelanotide. J Pharm Biomed Anal. PubMed · DOI
  3. Langan EA et al. (2010). Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?. Br J Dermatol. PubMed · DOI

Studies compiled from PubMed for informational purposes; many are preclinical or research-stage and do not constitute medical advice.